Autoantibodies Activating the Β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.02112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Atrial Tachycardia Provoked in the Presence of Activating Autoantibodies to Β2-Adrenergic Receptor in the Rabbit

Heart Rhythm
Cardiovascular MedicinePhysiologyCardiology
2013English

Increased Circulating Β2-Adrenergic Receptor Autoantibodies Are Associated With Smoking-Related Emphysema

Scientific Reports
Multidisciplinary
2017English

Adrenergic-Β2 Receptor Polymorphism and Athletic Performance

Journal of Human Genetics
Genetics
2010English

RGS2 Is a Primary Terminator of Β2-Adrenergic Receptor-Mediated Gi Signaling

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2011English

Nitric Oxide Modulates Β2-Adrenergic Receptor Palmitoylation and Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Crystal Structure of the Β2 Adrenergic Receptor–Gs Protein Complex

Nature
Multidisciplinary
2011English

Β2-Adrenergic Receptor Control of Endosomal PTH Receptor Signaling via Gβγ

Nature Chemical Biology
Cell BiologyMolecular Biology
2016English

The 3′-Untranslated Region of the Β2-Adrenergic Receptor mRNA Regulates Receptor Synthesis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Adrenergic Receptor Β2 (ADRB2); ADRB3; Muscarinic Acetylcholine Receptor M1 (CHRM1; HM1)

Science-Business eXchange
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy